My team worked with Diviner in the Spring. Diviner uses an expert network and predictive forecasting to estimate both stock price changes and optimal biotech research and development investment. Our team focused on collecting qualitative and quantitative data around over 300 "case study" stocks, as well as researching the biotech investment sphere. We summarized trends seen in the data, and provided proof-of-concept for quantitative data collection/analysis. Our team summarized our findings in multiple presentations, notably the mid-point update and final presentation. We also supplied a summative report to Diviner.